Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, ...

For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favorable bowel health-related quality of life (HRQOL).

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

The annual meeting of the American Society for Radiation Oncology was held from Sept. 27 to Oct. 1 in San Francisco, drawing ...

Ten-year STARS trial data show stereotactic ablative radiotherapy provides survival outcomes comparable to surgery in ...

Accuray (ARAY) announced that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7 System. 5D ...

Innovative NBTXR3 shows promise in enhancing radiotherapy for recurrent head and neck cancer, potentially transforming ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new ...

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend ...